Related references
Note: Only part of the references are listed.miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis
Chao Cheng et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Targeting Ubiquitin-Proteasome System With Copper Complexes for Cancer Therapy
Xin Chen et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Exosomes mediate intercellular transfer of non-autonomous tolerance to proteasome inhibitors in mixed-lineage leukemia
Maolin Ge et al.
CANCER SCIENCE (2020)
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Eric K. Rowinsky et al.
INVESTIGATIONAL NEW DRUGS (2020)
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
Meirong Zang et al.
ONCOGENESIS (2020)
Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence
Deniz Bakkalci et al.
JOURNAL OF GLOBAL HEALTH (2020)
A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma
Wen Liu et al.
ADVANCES IN THERAPY (2020)
ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis
Juan Feng et al.
CANCER RESEARCH (2020)
Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma
Mingdan Deng et al.
CANCERS (2020)
S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1
Dong-Fang Meng et al.
ONCOGENE (2020)
The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases
Gizem Celebi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection
Benjamin Fournier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Thomas Powles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
NF-κB in the New Era of Cancer Therapy
Baptiste Eluard et al.
TRENDS IN CANCER (2020)
The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification
Victor Ho-Fun Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Expression and clinical significance of S100 family genes in patients with melanoma
Ting-feng Xiong et al.
MELANOMA RESEARCH (2019)
Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
Kwai Fung Hui et al.
FRONTIERS IN ONCOLOGY (2019)
Mitochondrial metabolism promotes adaptation to proteotoxic stress
Peter Tsvetkov et al.
NATURE CHEMICAL BIOLOGY (2019)
Histocompatibility locus antigens regions contribute to the ethnicity bias of Epstein-Barr virus-associated nasopharyngeal carcinoma in higher-incidence populations
Nabanita Roy Chattopadhyay et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2019)
VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
Zixi Liang et al.
CELL DEATH & DISEASE (2019)
Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production
Jaeyeun Lee et al.
JOURNAL OF VIROLOGY (2019)
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies
Filipa Lynce et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression
Limei Liu et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Thorbald van Hall et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma
Rob J. A. Verhoeven et al.
FRONTIERS IN ONCOLOGY (2019)
Structure and Molecular Mechanism of ER Stress Signaling by the Unfolded Protein Response Signal Activator IRE1
Christopher J. Adams et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
Alexander Drilon et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2019)
Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model
Chandini M. Thirukkumaran et al.
BLOOD ADVANCES (2019)
Recent advances in metal nanoparticles in cancer therapy
Ankush Sharma et al.
JOURNAL OF DRUG TARGETING (2018)
RIG-I: a multifunctional protein beyond a pattern recognition receptor
Xiao-xiao Xu et al.
PROTEIN & CELL (2018)
Characterization of PD-L1 and PD-1 Expression and CD8+Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma
Noppadol Larbcharoensub et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
Hailong Ma et al.
BRITISH JOURNAL OF CANCER (2018)
Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment
Takeharu Ono et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study
Ya-Qin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B. Y. Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phylogenetic comparison of Epstein-Barr virus genomes
Su Jin Choi et al.
JOURNAL OF MICROBIOLOGY (2018)
NCCN Guidelines® Insights Head and Neck Cancers, Version 1.2018 Featured Updates to the NCCN Guidelines
A. Dimitrios Colevas et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
The Unfolded Protein Response and Cell Fate Control
Claudio Hetz et al.
MOLECULAR CELL (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Expression and purification of a rapidly degraded protein, TMEM8B-a, in mammalian cell line
Li Wang et al.
PROTEIN EXPRESSION AND PURIFICATION (2018)
A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study
Dong-Fang Meng et al.
JOURNAL OF CANCER (2018)
Latent Latent Membrane Protein 1 of Epstein-Barr Virus Promotes RIG-I Degradation Mediated by Proteasome Pathway
Chongfeng Xu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells
Heng Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation
Hao-Jiong Zhang et al.
PLOS PATHOGENS (2018)
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
Jillian A. Bristol et al.
PLOS PATHOGENS (2018)
Antitumor Research on Artemisinin and Its Bioactive Derivatives
Yunqin Zhang et al.
NATURAL PRODUCTS AND BIOPROSPECTING (2018)
SEOM clinical guidelines for the treatment of head and neck cancer (2017)
L. C. Iglesias Docampo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells
Lindsey M. Hutt-Fletcher
JOURNAL OF VIROLOGY (2017)
Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation
Guan-Min Jiang et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Chiun Hsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5
Hong-Lei Zhang et al.
JOURNAL OF VIROLOGY (2017)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
Recent Patents on Proteasome Inhibitors of Natural Origin
Daniela Correia da Silva et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2017)
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Thomas Efferth
SEMINARS IN CANCER BIOLOGY (2017)
The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in cancer therapy
Yuanbing Wu et al.
TRANSLATIONAL RESEARCH (2017)
Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors
Kwai Fung Hui et al.
VIRUSES-BASEL (2017)
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Leah Fitzsimmons et al.
VIRUSES-BASEL (2017)
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
Yvonne Y. Li et al.
NATURE COMMUNICATIONS (2017)
Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes
Ruda de Luna Almeida Santos et al.
NATURE COMMUNICATIONS (2017)
Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer
Sanaz Taromi et al.
ONCOTARGET (2017)
The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I
Chunyuan Zhao et al.
CELL REPORTS (2017)
Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes
Qian Zhu et al.
ONCOIMMUNOLOGY (2017)
Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells
Murat R. Gainullin et al.
SCIENTIFIC REPORTS (2017)
Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma
Yosuke Nakanishi et al.
CANCER AND METASTASIS REVIEWS (2017)
Structural Elucidation of a Nonpeptidic Inhibitor Specific for the Human Immunoproteasome
Haissi Cui et al.
CHEMBIOCHEM (2017)
Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (5i) Subunit of the Immunoproteasome
Izidor Sosic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal
Hugo Sousa et al.
IMMUNOBIOLOGY (2016)
Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
G. P. Soriano et al.
LEUKEMIA (2016)
VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal
Prabhakar Bastola et al.
MOLECULAR ONCOLOGY (2016)
Protein misfolding in the endoplasmic reticulum as a conduit to human disease
Miao Wang et al.
NATURE (2016)
Are HLA-E*0103 alleles predictive markers for nasopharyngeal cancer risk?
Hayet Douik et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
Hong Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition
Soojay Banerjee et al.
SCIENCE (2016)
Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
Dominik Dytfeld et al.
ONCOTARGET (2016)
Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing
Lijuan Hu et al.
FRONTIERS OF MEDICINE (2016)
Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study
Anna Maria Santoro et al.
SCIENTIFIC REPORTS (2016)
Genetic susceptibility to the endemic form of NPC
Jin-Xin Bei et al.
CHINESE CLINICAL ONCOLOGY (2016)
Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma (vol 24, pg 289, 2013)
Chungyee Leung-Hagesteijn et al.
CANCER CELL (2015)
O6-methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma
Shang Hung Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-Small-Cell Lung Cancer North Central Cancer Treatment Group (NCCTG)-N0321
Yujie Zhao et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard et al.
LANCET ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
Amani Makkouk et al.
CANCER RESEARCH (2015)
HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese
Yoon-Ming Chin et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells
X. Zhou et al.
ONCOGENE (2015)
Etiological factors of nasopharyngeal carcinoma
Sai Wah Tsao et al.
ORAL ONCOLOGY (2014)
Switching of EBV cycles between latent and lytic states
Takayuki Murata et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
Wenfeng Fang et al.
ONCOTARGET (2014)
Tumor Microenvironment and RIG-I Signaling Molecules in Epstein Barr Virus-Positive and -Negative Classical Hodgkin Lymphoma of the Elderly
Tsugumi Satoh et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2014)
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China
Yong Chen et al.
CANCER (2013)
Induction of Siglec-G by RNA Viruses Inhibits the Innate Immune Response by Promoting RIG-I Degradation
Weilin Chen et al.
CELL (2013)
From Bortezomib to other Inhibitors of the Proteasome and Beyond
Daniela Buac et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer
Tsukasa Seya et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): A trial of the Eastern Cooperative Oncology Group
Jill Gilbert et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
S100A14: Novel Modulator of Terminal Differentiation in Esophageal Cancer
Hongyan Chen et al.
MOLECULAR CANCER RESEARCH (2013)
Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein-Barr Virus
Kwai Fung Hui et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma
Yunbao Pan et al.
CANCER RESEARCH (2012)
Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
K. F. Hui et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells
T. Eichhorn et al.
MOLECULAR BIOSYSTEMS (2012)
S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest
Dipak Sapkota et al.
ORAL ONCOLOGY (2012)
Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma
Zhen Liu et al.
PROTEOMICS (2012)
Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000-2011 Rosetta Stone for NPC: Genetics, viral infection, and other environmental factors
Allan Hildesheim et al.
SEMINARS IN CANCER BIOLOGY (2012)
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
Christopher W. Dawson et al.
SEMINARS IN CANCER BIOLOGY (2012)
Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non-Small-Cell Lung Cancer: A California Cancer Consortium Trial
Primo N. Lara et al.
CLINICAL LUNG CANCER (2011)
Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells
Pok Man Hau et al.
PLOS ONE (2011)
Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)
Zhen Liu et al.
PLOS ONE (2011)
Chromosomal alterations in Malaysian patients with nasopharyngeal carcinoma analyzed by comparative genomic hybridization
M. N. Natasya Naili et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?
Philip Cohen et al.
CELL (2010)
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Craig M. Crews
CHEMISTRY & BIOLOGY (2010)
The p38 Signaling Pathway Upregulates Expression of the Epstein-Barr Virus LMP1 Oncogene
Pegah Johansson et al.
JOURNAL OF VIROLOGY (2010)
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
Jin-Xin Bei et al.
NATURE GENETICS (2010)
Tyrosine phosphorylation of cofilin at Y68 by v-Src leads to its degradation through ubiquitin-proteasome pathway
Y. Yoo et al.
ONCOGENE (2010)
Immunogenicity and efficacy of a DNA vaccine encoding a human anti-idiotype single chain antibody against nasopharyngeal carcinoma
Chen Luo et al.
VACCINE (2010)
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients
Chrystal U. Louis et al.
BLOOD (2009)
Nuclear Factor-κB Binds to the Epstein-Barr Virus LMP1 Promoter and Upregulates Its Expression
Pegah Johansson et al.
JOURNAL OF VIROLOGY (2009)
The LMP1 Promoter Can Be Transactivated Directly by NF-κB
Constantinos Demetriades et al.
JOURNAL OF VIROLOGY (2009)
Copper-Triggered Aggregation of Ubiquitin
Fabio Arnesano et al.
PLOS ONE (2009)
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Weiyi Fang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling
M. Samanta et al.
ONCOGENE (2008)
Recurrent Overexpression of c-IAP2 in EBV-Associated Nasopharyngeal Carcinomas: Critical Role in Resistance to Toll-like Receptor 3-Mediated Apoptosis
Luc Friboulet et al.
NEOPLASIA (2008)
Ubiquitination of MDM2 modulated by Epstein-Barr virus encoded latent membrane protein 1
Lili Li et al.
VIRUS RESEARCH (2007)
Modulation of LMP1 protein expression by EBV-encoded microRNAs
Angela Kwok Fung Lo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells
Asuka Nanbo et al.
EMBO JOURNAL (2007)
Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries
Bing-Jian Feng et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Ubiquitin stability and the Lys63-linked polyubiquitination site are compromised on copper binding
Danilo Milardi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
The enigmatic epidemiology of nasopharyngeal carcinoma
Ellen T. Chang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-κB and JNK signaling pathways
Gautier Goormachtigh et al.
JOURNAL OF VIROLOGY (2006)
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes
P Comoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer
DW Kim et al.
LUNG CANCER (2005)
EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies
P Busson et al.
TRENDS IN MICROBIOLOGY (2004)
Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway
AG Eliopoulos et al.
ONCOGENE (2003)
Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-κB and AP-1
L Deng et al.
CELL RESEARCH (2003)
A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus
HL Chen et al.
JOURNAL OF VIROLOGY (2003)
A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: Implication for the intense tumor infiltration by T lymphocytes and macrophages
KF Tang et al.
HUMAN PATHOLOGY (2001)
Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway - Targeting via ubiquitination of the N-terminal residue
S Aviel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
